These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 22683643)

  • 1. Age-dependent therapeutic effect of memantine in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Ramji S; Cooper JD; Pearce DA
    Neuropharmacology; 2012 Oct; 63(5):769-75. PubMed ID: 22683643
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary inhibition of AMPA receptors induces a prolonged improvement of motor performance in a mouse model of juvenile Batten disease.
    Kovács AD; Saje A; Wong A; Szénási G; Kiricsi P; Szabó E; Cooper JD; Pearce DA
    Neuropharmacology; 2011; 60(2-3):405-9. PubMed ID: 20971125
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Attenuation of AMPA receptor activity improves motor skills in a mouse model of juvenile Batten disease.
    Kovács AD; Pearce DA
    Exp Neurol; 2008 Jan; 209(1):288-91. PubMed ID: 17963751
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Moving towards therapies for juvenile Batten disease?
    Cooper JD
    Exp Neurol; 2008 Jun; 211(2):329-31. PubMed ID: 18400221
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcript and in silico analysis of CLN3 in juvenile neuronal ceroid lipofuscinosis and associated mouse models.
    Chan CH; Mitchison HM; Pearce DA
    Hum Mol Genet; 2008 Nov; 17(21):3332-9. PubMed ID: 18678598
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of the Ppt1(-/-) mouse model of infantile neuronal ceroid lipofuscinosis with the N-methyl-D-aspartate (NMDA) receptor antagonist memantine.
    Finn R; Kovács AD; Pearce DA
    J Child Neurol; 2013 Sep; 28(9):1159-68. PubMed ID: 24014511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Altered Cerebellar Short-Term Plasticity but No Change in Postsynaptic AMPA-Type Glutamate Receptors in a Mouse Model of Juvenile Batten Disease.
    Studniarczyk D; Needham EL; Mitchison HM; Farrant M; Cull-Candy SG
    eNeuro; 2018; 5(2):. PubMed ID: 29780879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Abnormally increased surface expression of AMPA receptors in the cerebellum, cortex and striatum of Cln3(-/-) mice.
    Kovács AD; Hof C; Pearce DA
    Neurosci Lett; 2015 Oct; 607():29-34. PubMed ID: 26375929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunosuppression alters disease severity in juvenile Batten disease mice.
    Seehafer SS; Ramirez-Montealegre D; Wong AM; Chan CH; Castaneda J; Horak M; Ahmadi SM; Lim MJ; Cooper JD; Pearce DA
    J Neuroimmunol; 2011 Jan; 230(1-2):169-72. PubMed ID: 20937531
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selectively increased sensitivity of cerebellar granule cells to AMPA receptor-mediated excitotoxicity in a mouse model of Batten disease.
    Kovács AD; Weimer JM; Pearce DA
    Neurobiol Dis; 2006 Jun; 22(3):575-85. PubMed ID: 16483786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of phosphodiesterase-4 inhibitors in juvenile Batten disease (CLN3).
    Aldrich A; Bosch ME; Fallet R; Odvody J; Burkovetskaya M; Rama Rao KV; Cooper JD; Drack AV; Kielian T
    Ann Neurol; 2016 Dec; 80(6):909-923. PubMed ID: 27804148
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Altered sensitivity of cerebellar granule cells to glutamate receptor overactivation in the Cln3(Δex7/8)-knock-in mouse model of juvenile neuronal ceroid lipofuscinosis.
    Finn R; Kovács AD; Pearce DA
    Neurochem Int; 2011 May; 58(6):648-55. PubMed ID: 21315126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Finding the most appropriate mouse model of juvenile CLN3 (Batten) disease for therapeutic studies: the importance of genetic background and gender.
    Kovács AD; Pearce DA
    Dis Model Mech; 2015 Apr; 8(4):351-61. PubMed ID: 26035843
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A knock-in reporter mouse model for Batten disease reveals predominant expression of Cln3 in visual, limbic and subcortical motor structures.
    Ding SL; Tecedor L; Stein CS; Davidson BL
    Neurobiol Dis; 2011 Feb; 41(2):237-48. PubMed ID: 20875858
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Altered gene expression in the eye of a mouse model for batten disease.
    Chattopadhyay S; Kingsley E; Serour A; Curran TM; Brooks AI; Pearce DA
    Invest Ophthalmol Vis Sci; 2004 Sep; 45(9):2893-905. PubMed ID: 15326100
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Complementary AAV9 Gene Delivery Partially Corrects Pathology Associated with Juvenile Neuronal Ceroid Lipofuscinosis (CLN3).
    Bosch ME; Aldrich A; Fallet R; Odvody J; Burkovetskaya M; Schuberth K; Fitzgerald JA; Foust KD; Kielian T
    J Neurosci; 2016 Sep; 36(37):9669-82. PubMed ID: 27629717
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photoreceptor phagosome processing defects and disturbed autophagy in retinal pigment epithelium of Cln3Δex1-6 mice modelling juvenile neuronal ceroid lipofuscinosis (Batten disease).
    Wavre-Shapton ST; Calvi AA; Turmaine M; Seabra MC; Cutler DF; Futter CE; Mitchison HM
    Hum Mol Genet; 2015 Dec; 24(24):7060-74. PubMed ID: 26450516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Therapeutic efficacy of antisense oligonucleotides in mouse models of CLN3 Batten disease.
    Centa JL; Jodelka FM; Hinrich AJ; Johnson TB; Ochaba J; Jackson M; Duelli DM; Weimer JM; Rigo F; Hastings ML
    Nat Med; 2020 Sep; 26(9):1444-1451. PubMed ID: 32719489
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glial cells are functionally impaired in juvenile neuronal ceroid lipofuscinosis and detrimental to neurons.
    Parviainen L; Dihanich S; Anderson GW; Wong AM; Brooks HR; Abeti R; Rezaie P; Lalli G; Pope S; Heales SJ; Mitchison HM; Williams BP; Cooper JD
    Acta Neuropathol Commun; 2017 Oct; 5(1):74. PubMed ID: 29041969
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurodevelopmental delay in the Cln3Deltaex7/8 mouse model for Batten disease.
    Osório NS; Sampaio-Marques B; Chan CH; Oliveira P; Pearce DA; Sousa N; Rodrigues F
    Genes Brain Behav; 2009 Apr; 8(3):337-45. PubMed ID: 19243453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.